Cargando…

Short-Term Circulating Tumor Cell Dynamics in Mouse Xenograft Models and Implications for Liquid Biopsy

MOTIVATION: Circulating tumor cells (CTCs) are widely studied using liquid biopsy methods that analyze fractionally-small peripheral blood (PB) samples. However, little is known about natural fluctuations in CTC numbers that may occur over short timescales in vivo, and how these may affect detection...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Amber L., Fitzgerald, Jessica E., Ivich, Fernando, Sontag, Eduardo D., Niedre, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677561/
https://www.ncbi.nlm.nih.gov/pubmed/33240820
http://dx.doi.org/10.3389/fonc.2020.601085
_version_ 1783612001097875456
author Williams, Amber L.
Fitzgerald, Jessica E.
Ivich, Fernando
Sontag, Eduardo D.
Niedre, Mark
author_facet Williams, Amber L.
Fitzgerald, Jessica E.
Ivich, Fernando
Sontag, Eduardo D.
Niedre, Mark
author_sort Williams, Amber L.
collection PubMed
description MOTIVATION: Circulating tumor cells (CTCs) are widely studied using liquid biopsy methods that analyze fractionally-small peripheral blood (PB) samples. However, little is known about natural fluctuations in CTC numbers that may occur over short timescales in vivo, and how these may affect detection and enumeration of rare CTCs from small blood samples. METHODS: We recently developed an optical instrument called “diffuse in vivo flow cytometry” (DiFC) that uniquely allows continuous, non-invasive counting of rare, green fluorescent protein expressing CTCs in large blood vessels in mice. Here, we used DiFC to study short-term changes in CTC numbers in multiple myeloma and Lewis lung carcinoma xenograft models. We analyzed CTC detections in over 100 h of DiFC data, and considered intervals corresponding to approximately 1%, 5%, 10%, and 20% of the PB volume. In addition, we analyzed changes in CTC numbers over 24 h (diurnal) periods. RESULTS: For rare CTCs (fewer than 1 CTC per ml of blood), the use of short DiFC intervals (corresponding to small PB samples) frequently resulted in no detections. For more abundant CTCs, CTC numbers frequently varied by an order of magnitude or more over the time-scales considered. This variance in CTC detections far exceeded that expected by Poisson statistics or by instrument variability. Rather, the data were consistent with significant changes in mean numbers of CTCs on the timescales of minutes and hours. CONCLUSIONS: The observed temporal changes can be explained by known properties of CTCs, namely, the continuous shedding of CTCs from tumors and the short half-life of CTCs in blood. It follows that the number of cells in a blood sample are strongly impacted by the timing of the draw. The issue is likely to be compounded for multicellular CTC clusters or specific CTC subtypes, which are even more rare than single CTCs. However, we show that enumeration can in principle be improved by averaging multiple samples, analysis of larger volumes, or development of methods for enumeration of CTCs directly in vivo.
format Online
Article
Text
id pubmed-7677561
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76775612020-11-24 Short-Term Circulating Tumor Cell Dynamics in Mouse Xenograft Models and Implications for Liquid Biopsy Williams, Amber L. Fitzgerald, Jessica E. Ivich, Fernando Sontag, Eduardo D. Niedre, Mark Front Oncol Oncology MOTIVATION: Circulating tumor cells (CTCs) are widely studied using liquid biopsy methods that analyze fractionally-small peripheral blood (PB) samples. However, little is known about natural fluctuations in CTC numbers that may occur over short timescales in vivo, and how these may affect detection and enumeration of rare CTCs from small blood samples. METHODS: We recently developed an optical instrument called “diffuse in vivo flow cytometry” (DiFC) that uniquely allows continuous, non-invasive counting of rare, green fluorescent protein expressing CTCs in large blood vessels in mice. Here, we used DiFC to study short-term changes in CTC numbers in multiple myeloma and Lewis lung carcinoma xenograft models. We analyzed CTC detections in over 100 h of DiFC data, and considered intervals corresponding to approximately 1%, 5%, 10%, and 20% of the PB volume. In addition, we analyzed changes in CTC numbers over 24 h (diurnal) periods. RESULTS: For rare CTCs (fewer than 1 CTC per ml of blood), the use of short DiFC intervals (corresponding to small PB samples) frequently resulted in no detections. For more abundant CTCs, CTC numbers frequently varied by an order of magnitude or more over the time-scales considered. This variance in CTC detections far exceeded that expected by Poisson statistics or by instrument variability. Rather, the data were consistent with significant changes in mean numbers of CTCs on the timescales of minutes and hours. CONCLUSIONS: The observed temporal changes can be explained by known properties of CTCs, namely, the continuous shedding of CTCs from tumors and the short half-life of CTCs in blood. It follows that the number of cells in a blood sample are strongly impacted by the timing of the draw. The issue is likely to be compounded for multicellular CTC clusters or specific CTC subtypes, which are even more rare than single CTCs. However, we show that enumeration can in principle be improved by averaging multiple samples, analysis of larger volumes, or development of methods for enumeration of CTCs directly in vivo. Frontiers Media S.A. 2020-11-06 /pmc/articles/PMC7677561/ /pubmed/33240820 http://dx.doi.org/10.3389/fonc.2020.601085 Text en Copyright © 2020 Williams, Fitzgerald, Ivich, Sontag and Niedre http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Williams, Amber L.
Fitzgerald, Jessica E.
Ivich, Fernando
Sontag, Eduardo D.
Niedre, Mark
Short-Term Circulating Tumor Cell Dynamics in Mouse Xenograft Models and Implications for Liquid Biopsy
title Short-Term Circulating Tumor Cell Dynamics in Mouse Xenograft Models and Implications for Liquid Biopsy
title_full Short-Term Circulating Tumor Cell Dynamics in Mouse Xenograft Models and Implications for Liquid Biopsy
title_fullStr Short-Term Circulating Tumor Cell Dynamics in Mouse Xenograft Models and Implications for Liquid Biopsy
title_full_unstemmed Short-Term Circulating Tumor Cell Dynamics in Mouse Xenograft Models and Implications for Liquid Biopsy
title_short Short-Term Circulating Tumor Cell Dynamics in Mouse Xenograft Models and Implications for Liquid Biopsy
title_sort short-term circulating tumor cell dynamics in mouse xenograft models and implications for liquid biopsy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677561/
https://www.ncbi.nlm.nih.gov/pubmed/33240820
http://dx.doi.org/10.3389/fonc.2020.601085
work_keys_str_mv AT williamsamberl shorttermcirculatingtumorcelldynamicsinmousexenograftmodelsandimplicationsforliquidbiopsy
AT fitzgeraldjessicae shorttermcirculatingtumorcelldynamicsinmousexenograftmodelsandimplicationsforliquidbiopsy
AT ivichfernando shorttermcirculatingtumorcelldynamicsinmousexenograftmodelsandimplicationsforliquidbiopsy
AT sontageduardod shorttermcirculatingtumorcelldynamicsinmousexenograftmodelsandimplicationsforliquidbiopsy
AT niedremark shorttermcirculatingtumorcelldynamicsinmousexenograftmodelsandimplicationsforliquidbiopsy